Get quick answers to your questions about the article from our AI researcher chatbot
{'id': 'https://openalex.org/W3142026086', 'doi': None, 'title': 'Intracranial hemorrhage in patients treated with bevacizumab:Report of two cases', 'display_name': 'Intracranial hemorrhage in patients treated with bevacizumab:Report of two cases', 'publication_year': 2011, 'publication_date': '2011-01-01', 'ids': {'openalex': 'https://openalex.org/W3142026086', 'mag': '3142026086'}, 'language': 'zh-cn', 'primary_location': {'is_oa': False, 'landing_page_url': 'http://www.cqvip.com/QK/84123X/201139/40184605.html', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S4306541008', 'display_name': '世界胃肠病学杂志:英文版', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': None, 'host_organization_name': None, 'host_organization_lineage': [], 'host_organization_lineage_names': [], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': [], 'open_access': {'is_oa': False, 'oa_status': 'closed', 'oa_url': None, 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5029702436', 'display_name': 'Takeshi', 'orcid': None}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': 'Takeshi', 'raw_affiliation_strings': [], 'affiliations': []}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5104929151', 'display_name': 'Tadahiro Sasaki', 'orcid': 'https://orcid.org/0000-0002-3965-949X'}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': 'Nishimura', 'raw_affiliation_strings': [], 'affiliations': []}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5083756922', 'display_name': 'Makoto Makoto', 'orcid': None}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': 'Makoto', 'raw_affiliation_strings': [], 'affiliations': []}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5049000409', 'display_name': 'Furihata', 'orcid': None}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': 'Furihata', 'raw_affiliation_strings': [], 'affiliations': []}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5001129898', 'display_name': 'Hideyuki', 'orcid': None}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': 'Hideyuki', 'raw_affiliation_strings': [], 'affiliations': []}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5060426531', 'display_name': 'M Kubo', 'orcid': None}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': 'Kubo', 'raw_affiliation_strings': [], 'affiliations': []}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5070082697', 'display_name': 'Masao Masao', 'orcid': None}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': 'Masao', 'raw_affiliation_strings': [], 'affiliations': []}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5057639711', 'display_name': 'Tani', 'orcid': None}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': 'Tani', 'raw_affiliation_strings': [], 'affiliations': []}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5025545716', 'display_name': 'Senichiro', 'orcid': None}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': 'Senichiro', 'raw_affiliation_strings': [], 'affiliations': []}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5085759485', 'display_name': 'Agawa', 'orcid': None}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': 'Agawa', 'raw_affiliation_strings': [], 'affiliations': []}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5067723577', 'display_name': 'Ryuhei', 'orcid': None}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': 'Ryuhei', 'raw_affiliation_strings': [], 'affiliations': []}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5011952523', 'display_name': 'Setoyama', 'orcid': None}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': 'Setoyama', 'raw_affiliation_strings': [], 'affiliations': []}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5038870796', 'display_name': 'Tomikatsu', 'orcid': None}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': 'Tomikatsu', 'raw_affiliation_strings': [], 'affiliations': []}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5077013263', 'display_name': 'Akihiro Toyoda', 'orcid': None}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': 'Toyoda', 'raw_affiliation_strings': [], 'affiliations': []}], 'institution_assertions': [], 'countries_distinct_count': 0, 'institutions_distinct_count': 0, 'corresponding_author_ids': [], 'corresponding_institution_ids': [], 'apc_list': None, 'apc_paid': None, 'fwci': 0.0, 'has_fulltext': False, 'cited_by_count': 0, 'citation_normalized_percentile': {'value': 0.0, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 0, 'max': 66}, 'biblio': {'volume': '17', 'issue': '39', 'first_page': '4440', 'last_page': '4444'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T10129', 'display_name': 'Gliomas', 'score': 0.9954, 'subfield': {'id': 'https://openalex.org/subfields/2716', 'display_name': 'Genetics'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, 'topics': [{'id': 'https://openalex.org/T10129', 'display_name': 'Gliomas', 'score': 0.9954, 'subfield': {'id': 'https://openalex.org/subfields/2716', 'display_name': 'Genetics'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T11600', 'display_name': 'Management of Brain Metastases in Cancer Patients', 'score': 0.9946, 'subfield': {'id': 'https://openalex.org/subfields/2740', 'display_name': 'Pulmonary and Respiratory Medicine'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T10420', 'display_name': 'Pathophysiology and Management of Cerebral Aneurysms', 'score': 0.993, 'subfield': {'id': 'https://openalex.org/subfields/2728', 'display_name': 'Neurology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/endovascular-treatment', 'display_name': 'Endovascular Treatment', 'score': 0.515267}, {'id': 'https://openalex.org/keywords/intracranial-tumor', 'display_name': 'Intracranial tumor', 'score': 0.45121598}], 'concepts': [{'id': 'https://openalex.org/C2777802072', 'wikidata': 'https://www.wikidata.org/wiki/Q413299', 'display_name': 'Bevacizumab', 'level': 3, 'score': 0.995589}, {'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.8845881}, {'id': 'https://openalex.org/C526805850', 'wikidata': 'https://www.wikidata.org/wiki/Q188874', 'display_name': 'Colorectal cancer', 'level': 3, 'score': 0.5744694}, {'id': 'https://openalex.org/C2992168552', 'wikidata': 'https://www.wikidata.org/wiki/Q233309', 'display_name': 'Intracranial tumor', 'level': 2, 'score': 0.45121598}, {'id': 'https://openalex.org/C126322002', 'wikidata': 'https://www.wikidata.org/wiki/Q11180', 'display_name': 'Internal medicine', 'level': 1, 'score': 0.31376076}, {'id': 'https://openalex.org/C141071460', 'wikidata': 'https://www.wikidata.org/wiki/Q40821', 'display_name': 'Surgery', 'level': 1, 'score': 0.27631354}, {'id': 'https://openalex.org/C2776694085', 'wikidata': 'https://www.wikidata.org/wiki/Q974135', 'display_name': 'Chemotherapy', 'level': 2, 'score': 0.19511583}, {'id': 'https://openalex.org/C121608353', 'wikidata': 'https://www.wikidata.org/wiki/Q12078', 'display_name': 'Cancer', 'level': 2, 'score': 0.12418032}], 'mesh': [], 'locations_count': 1, 'locations': [{'is_oa': False, 'landing_page_url': 'http://www.cqvip.com/QK/84123X/201139/40184605.html', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S4306541008', 'display_name': '世界胃肠病学杂志:英文版', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': None, 'host_organization_name': None, 'host_organization_lineage': [], 'host_organization_lineage_names': [], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': None, 'sustainable_development_goals': [{'id': 'https://metadata.un.org/sdg/3', 'score': 0.45, 'display_name': 'Good health and well-being'}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 0, 'referenced_works': [], 'related_works': [], 'abstract_inverted_index': {'有': [0], 'bevacizumab': [1, 15, 17, 23, 37, 43, 45], '的治疗,一个': [2], 'antiangiogenic': [3], '代理人,在病人与变形或': [4], 'unresectable': [5], 'colorectal': [6, 11, 21, 31], '癌症不到': [7], '4': [8], '年以前在日本被同意。Bevacizumab': [9], '与变形': [10], '癌症改进病人的幸存;然而,它可以导致象流血那样的复杂并发症,它有时是致命的。因为治疗的潜在的风险超过它的好处,': [12], 'Bevacizumab': [13], '应该仅仅在小心的考虑以后被管理。因此,药品的公司不与大脑转移为病人推荐': [14], '治疗。当一些报告支持': [16], '的小心的使用时,其它报导与转移在病人禁止它的使用到中央神经系统(CNS': [18], ')': [19, 29], '不总是是必要的,包括大脑。因此,在有大脑转移的': [20], '癌症病人的': [22], '治疗是争论的,并且大脑转移是否在反脉管的': [24], 'endothelial': [25], '生长期间是为': [26], 'intracranial': [27, 41, 47, 49], '出血的一个风险因素,是不清楚的因素(VEGF': [28], '治疗。没有大脑转移,我们与周期性的': [30], '癌症报导一个': [32], '65': [33, 35], '岁的人和一个': [34], '岁的人;分别地,这些病人在': [36], '的管理以后开发了': [38], 'multifocal': [39], '和独居的': [40], '出血。我们的调查结果建议就算病人没在': [42], '治疗以前有大脑转移并且也建议大脑转移不是为有': [44], '治疗的': [46], '出血的一个风险因素,那': [48], '出血能发生。这些调查结果也询问在': [50], 'anti-VEGF': [51], '上从临床的试用与大脑转移排除病人的必要性治疗。': [52]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W3142026086', 'counts_by_year': [], 'updated_date': '2024-09-15T12:05:26.526361', 'created_date': '2021-04-13'}